---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-054479"
form_type: "8-K"
ticker: "DH"
cik: "0001861795"
company_name: "Definitive Healthcare Corp."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T20:36:43.739023+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Definitive Healthcare Q1 revenue $63.5M (+7% YoY); Adj. EBITDA margin 32%; $20M buyback

## Summary
- Revenue $63.5M, +7% YoY from $59.2M; net loss narrowed to $12.7M from $16.0M.
- Adjusted Net Income $13.0M vs $9.1M; Adjusted EBITDA $20.0M (32% margin vs 26%).
- Enterprise customers grew 6% YoY to 559; added 30 clients with >$100K ARR.
- Board authorized $20M stock repurchase program through end of 2024.
- FY2024 guidance: revenue $255-$261M (+1-4%); Q2 revenue $62-$63.5M (+2-4%).

## SEC filing metadata
- accession: 0000950170-24-054479
- form_type: 8-K
- ticker: DH
- cik: 0001861795
- company_name: Definitive Healthcare Corp.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861795/000095017024054479/0000950170-24-054479-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861795/000095017024054479/dh-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-054479
- JSON: https://secwatch.observer/filing/0000950170-24-054479.json
- Plain text: https://secwatch.observer/filing/0000950170-24-054479.txt

## Key facts
- Earnings Releases
  Definitive Healthcare Corp. reported first quarter ended March 31, 2024 results: revenue $63.5 million, net income $(12.7) million.
  - Period: first quarter ended March 31, 2024
  - Revenue: $63.5 million
  - Net income: $(12.7) million
  - Result: reported results
  source text: EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2024 First quarter revenue grew 7% year-over-year to $63.5 million Framingham, MA (May 7, 2024) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000095017024054479/0000950170-24-054479-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.